Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Neuroendocrine Carcinoma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Endocrine Neoplasm
Neuroendocrine Neoplasm
Neuroendocrine Carcinoma

Subtype

Neuroendocrine Carcinoma

CI-CAN-00001275NECExplore in graph →

514 active trials12 approved drugs28 evidence items

NCIt: C3773
OncoTree: NECNOS
MeSH: D018278

Overview
Statistics
Survival
Genomics4
Variants & evidence28
Drugs16
Trials1533
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

1,533 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 514
Recruiting: 261
Ph III recruiting: 29
Growth YoY: +4.2%
Industry share: 38%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (213)

StatusAll Active (any)Completed 485 Recruiting 313 Unknown 210 Terminated 175 Active Not Recruiting 159 Not Yet Recruiting 115 Withdrawn 44 Enrolling By Invitation 11 Approved For Marketing 7 Suspended 6 No Longer Available 4 Available 4

PhaseAll Early Phase 1 10 N/A 112 Phase 1 454 Phase 2 821 Phase 3 149 Phase 4 14

No study matches these filters